Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options

Uses and Nonuses of Patented Inventions

The Disclosure and Licensing of University Inventions

We examine the interplay of the three major university actors in technology transfer from universities to industry: the faculty, the technology transfer office (TTO), and the central administration. We model the faculty as an agent of the administration, and the TTO as an agent of both the faculty and the administration. Empirical tests of the theory are based on evidence from our survey of 62 ...

The dual frontier: Patented inventions and prior scientific advance.

The extent to which scientific advances support marketplace inventions is largely unknown. We study 4.8 million U.S. patents and 32 million research articles to determine the minimum citation distance between patented inventions and prior scientific advances. We find that most cited research articles (80%) link forward to a future patent. Similarly, most patents (61%) link backward to a prior r...

Proofs and Prototypes for Sale: The Licensing of University Inventions

Proponents of the Bayh-Dole Act argue that industrial use of federally-funded research would be reduced without university patent licensing. Our survey of U.S. universities supports this view, emphasizing the embryonic state of most technologies licensed and the need for inventor cooperation in commercialization. Thus, for most university inventions, there is a moral hazard problem with invento...

A pilot survey on the licensing of DNA inventions.

Despite ethical concerns about gene patents, virtually no empirical evidence exists to support claims about either positive or negative effects, and extremely little is known about the intellectual property protection strategies of firms and universities. This article discusses the results of a pilot study to examine patenting and licensing philosophies, policies, and practices of different typ...